• Home
• Register for Updates
• Contact Us

NASDAQ: 32.33 -0.21 -0.65% Volume: 114,490 June 19, 2013

• Who We Are
  • Overview
  • Message from CEO
  • Leadership
  • Board of Directors
  • Contact Us
• What We Do
  • Portfolio
  • Business Model
  • Major Assets
  • Collaborations
    • GlaxoSmithKline
    • Onyx
    • Merck
    • Bristol-Myers Squibb
    • Pfizer
    • Exelixis
    • Chiva Pharmaceuticals
    • Baxter
    • The Medicines Company
    • SAGE
    • Lundbeck
    • Retrophin
    • Spectrum
    • MEI Pharma
    • Sanofi
    • Rib-X
  • Royalty Table
• Licensing Opportunities
  • Fablyn
  • SARM
  • Diabetes Portfolio
  • EPO/GCSF
  • IV Topiramate
  • LGD-313
  • LGD-461
  • LGD-3437
  • CRTH2 Antagonist
  • Contact Business Development
• Captisol
• News
  • News
  • Events
• Investors
  • Investor Overview
  • News & Events
    • Press Releases
    • Investor Calendar
    • Webcasts & Presentations
  • Analyst Coverage
  • SEC Filings
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Price Lookup
  • Corporate Governance
  • Email Alerts
  • Contact Us
  • RSS Feeds

• 
  E-mail Page
  |
• 
  RSS Feeds
  |
• 
  E-mail Alerts
  |
• 
  Financial Tear Sheet

• Terms of Use
• Site Map

Powered By Q4 Web Systems 3.8.2.5449